NCT02063334View on ClinicalTrials.gov

The Effect of a High-dose Oral Vitamin D3 Bolus on Serum 25(OH)D3 and Vitamin D Receptor Target Gene Expression

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Vitamin D Receptor Target Gene ExpressionSerum 25(OH)D Concentration
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

In total 25 pills will be taken by the subjects, each containing 80 micrograms of vitamin D3 or placebo. Of the 25 pills, 13 will be taken in the morning with breakfast and 12 with lunch.

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

70211

University of Eastern Finland, Kuopio

All Listed Sponsors
lead

University of Eastern Finland

OTHER

NCT02063334 - The Effect of a High-dose Oral Vitamin D3 Bolus on Serum 25(OH)D3 and Vitamin D Receptor Target Gene Expression | Biotech Hunter | Biotech Hunter